Search

everythinglearnresearchcommunity

for

Search:↓

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

L-cystine and vitamin B6 at high doses prevented hair loss in mice treated with a chemotherapy drug.

Lipid–polymer hybrid nanoparticles can improve genome editing delivery and outcomes.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

The document says that early treatment of Acne Vulgaris is important to prevent scarring and that adult onset acne is common in women, often due to hormonal imbalances.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

A very low-calorie ketogenic diet is effective for quick weight loss and improving health in obese patients, with careful management of side effects and maintenance.

The document describes a treatment for excessive hair growth in a teenage girl using medication and birth control, but does not report the results.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Eye drops with β-blockers may cause hair loss.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Plant-based drugs are effective and safe alternatives for managing PCOS symptoms.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.